Biotest Aktiengesellschaft
Save
1.33B
Market cap
23.7x
Current P/E
526.32x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas.
Similar securities
Based on sector and market capitalization
Report issue